AIM ImmunoTech, Inc.
(NYSE Amex Equities : AIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.15%247.721.3%$844.18m
MRNAModerna, Inc. 2.92%69.870.0%$763.28m
NVAXNovavax, Inc. -6.19%108.3696.5%$693.95m
IMMUImmunomedics, Inc. 0.22%85.5311.0%$600.97m
GILDGilead Sciences, Inc. 0.02%65.051.0%$599.14m
REGNRegeneron Pharmaceuticals, Inc. -1.73%555.242.7%$445.10m
BIIBBiogen, Inc. -0.32%274.481.6%$332.97m
VRTXVertex Pharmaceuticals, Inc. -2.24%265.391.9%$329.17m
ILMNIllumina, Inc. -0.85%295.503.5%$313.09m
SRNESorrento Therapeutics, Inc. -0.53%9.431.5%$274.82m
ALXNAlexion Pharmaceuticals, Inc. -0.36%113.722.0%$266.55m
BMRNBioMarin Pharmaceutical, Inc. 1.30%79.384.3%$239.49m
MNTAMomenta Pharmaceuticals, Inc. -0.13%52.263.0%$237.34m
VXRTVaxart, Inc. 3.01%8.220.0%$213.57m
SGENSeattle Genetics, Inc. 3.01%180.946.0%$194.15m

Company Profile

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.